MARK RICHARD J Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$659,930.06
Insider Sells Quantity
10
Insider Sells Sum
$5.9M

Insider Activity of MARK RICHARD J

According to the SEC Form 4 filings, MARK RICHARD J, being in a position of

  1. director at Sempra,
    оver the last 12 months, has bought 2692 shares for $251,164, and sold 0 shares,
    over all time since 2024-05-17, has bought 11777 shares for $901,095, and sold 0 shares.

Biography of MARK RICHARD J

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$251,164150
Sells
$2,634,200150

Comparison of Insiders on Amount of Buys and Sells

2026-09-10SaleTenet Healthcare Corporation
THC
director
10,000
0.012%
$263.42$2.63M+0.1%
2026-03-11PurchaseSempra
SRE
director
2,692
0.0004%
$93.30$251,164-1.12%
2025-03-06PurchaseSempra
SRE
director
7,160
0.0011%
$69.81$499,840+20.71%
2024-05-17PurchaseSempra
SRE
director
1,925
0.0003%
$77.97$150,092+4.86%
2024-03-12SaleTenet Healthcare Corporation
THC
director
14,000
0.0139%
$98.98$1.39M+35.78%
2022-03-31SaleAmeren Corporation
AEE
6,000
0.0023%
$93.67$562,020-4.89%
2022-03-10SaleAmeren Corporation
AEE
3,500
0.0014%
$87.37$305,795+2.59%
2022-03-09SaleTenet Healthcare Corporation
THC
6,000
0.0056%
$90.47$542,820-36.26%
2021-09-30SaleAmeren Corporation
AEE
6,000
0.0024%
$82.18$493,080+10.06%
2021-03-31SaleAmeren Corporation
AEE
6,000
0.0023%
$81.17$487,020+5.83%
2020-11-19SaleAmeren Corporation
AEE
12,600
0.0051%
$78.00$982,800+7.91%
2016-06-02SaleAmeren Corporation
AEE
18,600
0.0076%
$48.89$909,354+7.85%
2009-11-25SaleAmeren Corporation
AEE
Chmn & President of Subsidiary
1,907
0.0009%
$25.91$49,410+4.78%
2007-11-15SaleAmeren Corporation
AEE
Chmn & President of Subsidiary
3,574
0.0017%
$52.27$186,813-14.79%
2005-05-31PurchaseAmeren Corporation
AEE
Chmn & President of Subsidiary
183
<0.0001%
$54.63$9,998-2.26%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.